Chong Kun Dang Pharmaceutical Corp. (KRX:185750)

KRX:185750 Revenue

Chong Kun Dang Pharmaceutical had revenue of 447.77B KRW in the quarter ending March 31, 2026, with 11.67% growth. This brings the company's revenue in the last twelve months to 1.74T, up 6.97% year-over-year. In the year 2025, Chong Kun Dang Pharmaceutical had annual revenue of 1.69T with 6.68% growth.

• Revenue (ttm): 1.74T
• Revenue Growth: +6.97%
• P/S Ratio: 0.56
• Revenue / Employee: 794.16M
• Employees: 2,253
• Market Cap: 973.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.69T	105.97B	6.68%
Dec 31, 2024	1.59T	-82.97B	-4.97%
Dec 31, 2023	1.67T	181.06B	12.17%
Dec 31, 2022	1.49T	144.79B	10.78%
Dec 31, 2021	1.34T	40.55B	3.11%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 15, 2026

Data Sources Report a data error